Introduction
============

Noncoding RNP particles form the molecular machines effecting mRNA splicing and protein synthesis, and they also play regulatory roles at multiple steps during gene expression. Many noncoding RNPs are stable assemblies, and several studies have revealed that their formation requires dedicated cellular machineries, even when the RNP can be assembled in vitro from purified components ([@bib46]). One of the best studied cases is the formation of the heptameric Sm ring on spliceosomal small nuclear RNAs by the SMN (survival of motor neurons) complex ([@bib20], [@bib21]). Exhaustive studies on this model system have shown that assembly factors perform multiple roles ([@bib4]; [@bib10]; [@bib69]; [@bib70]; [@bib24]). First, they facilitate RNP formation by preassembling core proteins in the absence of RNA, thereby stabilizing labile assembly intermediates. Second, they provide a structural scaffold and organize Sm proteins in a manner that promotes assembly with the target RNAs. Third, they prevent nonspecific RNA binding. Hence, by interacting at multiple sites with the core RNP proteins and the target RNAs, RNP assembly factors ensure efficiency, specificity, and quality control of RNP production.

H/ACA small nucleolar RNPs (snoRNPs) are another well-studied class of noncoding RNPs ([@bib31], [@bib32]; [@bib53]; [@bib38]; [@bib62]). Studies of their biogenesis also revealed the formation of a protein-only complex containing some core proteins and assembly factors ([@bib61]; [@bib36]; [@bib60]). These studies also showed the involvement of a general assembly machinery, the HSP90--R2TP chaperone complex ([@bib30]; [@bib6]), and in particular the role of its AAA^+^ ATPases RuvBL1 and RuvBL2, which promote dissociation of the assembly factor SHQ1 ([@bib42]). Finally, it was found that the pre-snoRNP factor NAF1 inhibits the activity of the immature RNP particle ([@bib25]; [@bib60]).

In contrast to the cases of snRNPs and H/ACA snoRNPs in which protein-only complexes are preformed by assembly factors, in vitro studies of box C/D snoRNPs have suggested an ordered assembly pathway that takes place directly on the snoRNA ([@bib52]). Box C/D snoRNPs catalyze 2′-*O*-methylation of target RNAs ([@bib9]; [@bib33]; [@bib31]; [@bib53]; [@bib38]; [@bib62]). They contain four core proteins assembled around a pseudodimeric guide snoRNA, which contains a C/D and a C′/D′ motif. In humans, box C/D snoRNPs are composed of the protein 15.5K, which directly recognizes the snoRNA K-turn (kink turn) C/D motif ([@bib63]), and Nop56/Nop58, two homologous proteins that each bind a copy of the 2′-*O*-methylase Fibrillarin ([@bib1]). Nop56 and Nop58 contain a coiled-coil domain, which allows them to heterodimerize, thereby connecting the C/D and C′/D′ RNA motifs and creating the pseudodimeric structure of the snoRNP ([@bib1]; [@bib39]). Nop56 and Nop58 also contain a Nop domain, which is an RNP binding module that interacts with a preformed 15.5K--snoRNA complex ([@bib40]). Several in vitro studies have led to the hypothesis that snoRNP assembly is initiated by the binding of the 15.5K to the snoRNA C/D motif followed by recruitment of the Nop58/Fibrillarin dimer, interaction with Nop56/Fibrillarin bound at the C′/D′ motif, and formation of the mature, active structure ([@bib64]). In vivo, assembly of C/D snoRNP requires several assembly factors: the HSP90--R2TP chaperone complex that is also required for H/ACA snoRNP biogenesis ([@bib47]; [@bib6]; [@bib72]) and two specific factors, NUFIP, which connects the 15.5K to the R2TP ([@bib6]; [@bib51]), and BCD1, whose function remains poorly characterized ([@bib50]). Nop58 and/or 15.5K are probable clients of HSP90 ([@bib6]), and the RuvBL1/RuvBL2 subunits of the R2TP complex have been hypothesized to catalyze a remodeling event on the immature C/D snoRNP ([@bib65]; [@bib6]). In agreement, they make ATP-dependent interactions with core C/D proteins and other assembly factors ([@bib45]; [@bib13]). However, the nature of this remodeling event and more generally how the assembly factors function and what is the in vivo assembly pathway of box C/D snoRNPs have remained poorly characterized. Here, we use quantitative proteomics and structural biology to identify key features of snoRNP biogenesis: an early protein-only complex that contains 15.5K and Nop58 together with assembly factors and a late step leading to the release of NUFIP and the activation of snoRNP catalytic activity.

Results
=======

hBCD1 SILAC proteomics identifies ZNHIT3 as a new C/D snoRNP assembly factor
----------------------------------------------------------------------------

To characterize the C/D snoRNP assembly pathway in vivo, we performed stable isotope labeling by amino acids in cell culture (SILAC) proteomic experiments using a variety of snoRNP assembly factors as baits. We initiated our analysis with Bcd1p, an essential protein in yeast that is required for the accumulation of box C/D snoRNPs ([@bib50]), but whose function is poorly characterized. We cloned the human homologue of BCD1 (ZNHIT6, referred to as hBCD1; see [Table S1](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp1} for the nomenclature), fused it to GFP, and stably expressed it in U2OS cells. Cell extracts were fractionated using differential detergent treatments, to yield a first fraction extracted in 0.1% NP-40 that contains cytoplasmic and highly soluble nucleoplasmic material (referred to as "more extractable fraction"), and a second fraction, sonicated and extracted in 1% NP-40 and 0.5% deoxycholate and which contains less easily extractable nucleoplasmic material together with nucleoli ([@bib8]; "less extractable fraction"). Each fraction was immunoprecipitated using anti-GFP antibodies and analyzed by quantitative mass spectrometry (MS) against a control purification performed simultaneously with the parental U2OS cells ([Fig. 1 A](#fig1){ref-type="fig"}). Proteins were considered as hits if they had a SILAC ratio (specific immunoprecipitation \[IP\]/control IP) \>3.5 or if their SILAC ratio was between 1.5 and 3.5 but with a frequency of detection in unrelated IPs of \<25% (see [@bib7]; hit lists in [Table S3](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp2}). In the highly extractable fraction, five proteins stood out from the background: the bait GFP-hBCD1, the R2TP components RuvBL1 and RuvBL2, the snoRNP assembly factor NUFIP, and a small HIT Zn-finger protein not previously implicated in snoRNP biogenesis: ZNHIT3. In the less extractable fraction, less bait was recovered, and only RuvBL1 could be identified as a specific partner. The protein 15.5K was also detected in the IP, albeit with low SILAC ratio, and the specificity of this interaction was thus verified by IP/Western blotting ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp3}). To investigate the protein--protein interactions responsible for the formation of these complexes, we performed yeast two-hybrid assays ([Fig. 1 B](#fig1){ref-type="fig"}). This revealed a specific interaction between hBCD1 and RuvBL2, which was consistent with the large amount of RuvBL proteins copurifying with hBCD1 in the SILAC assay and with previous protein--protein interaction data ([@bib44]). We also observed an interaction between NUFIP and ZNHIT3 ([Fig. 1 B](#fig1){ref-type="fig"}). This interaction did not involve the PEP domain of NUFIP that binds 15.5K, and this suggested that a ternary complex could be formed between NUFIP, ZNHIT3, and 15.5K. In agreement, when NUFIP was coexpressed in the two-hybrid strain, an interaction could be detected between 15.5K and ZNHIT3 (Fig. S1 B). The interaction between NUFIP and ZNHIT3 appeared conserved throughout evolution because the yeast homologues of these proteins, Rsa1p and Hit1p, were also reported to interact in high-throughput interaction datasets ([@bib26]), and we could confirm that this is a direct interaction by GST pull-down with proteins produced in vitro (Fig. S1 C). To further confirm the interaction between NUFIP and ZNHIT3, we coprecipitated the two proteins ([Fig. 1 C](#fig1){ref-type="fig"}). Extracts from stable clones of 293T cells expressing GST-tagged versions of either NUFIP or ZNHIT3 were immunopurified using glutathione beads and analyzed by Western blots with NUFIP and ZNHIT3 antibodies. NUFIP copurified with GST-ZNHIT3, and conversely, ZNHIT3 copurified with GST-NUFIP. We then determined the intracellular localization of GFP-ZNHIT3 in transiently transfected cells using fluorescence microscopy. ZNHIT3 localized mainly in the nucleoplasm with some cytoplasmic staining, in a manner similar to the localization of NUFIP ([@bib3]). Collectively, these data indicate that ZNHIT3 is a partner of NUFIP, and its copurification with hBCD1 suggested a role in C/D snoRNP biogenesis.

![**hBCD1 identifies a new snoRNP assembly factor.** (A) GFP-hBCD1 was purified from more and less extractable fractions of U2OS cells, and pellets were analyzed by SILAC proteomic. X axis: protein abundance (Log~10~); Y axis: SILAC ratios (specific vs. control IP). LC, liquid chromatography; H/L, heavy/light; MW, molecular weight. (B) Yeast two-hybrid assays with ZNHIT3, hBCD1, and snoRNP assembly factors and core proteins. Alix is used as a negative control. Fib, Fibrillarin; Nter, N terminal; Cter, C terminal. (C) Co-IP assays between NUFIP and ZNHIT3. Extracts from 293T cells stably expressing GST-NUFIP and GST-ZNHIT3 were purified on glutathione beads and analyzed by Western blots (WB). (D) Intracellular localization of GFP-ZNHIT3. Microscopy images of HeLa cells transfected with a GFP-ZNHIT3 expression vector and labeled with DAPI to stain nuclei. Bar, 10 µm.](JCB_201404160_Fig1){#fig1}

ZNHIT3 proteomics identifies an RNase-resistant complex composed of two C/D core proteins and five assembly factors
-------------------------------------------------------------------------------------------------------------------

To explore the role of ZNHIT3, we performed a proteomic experiment using GFP-ZNHIT3 as the bait. In this experiment, we used a triple SILAC encoding scheme to compare RNase-treated and untreated extracts and to determine the contribution of RNA in the complexes observed ([Figs. 2 A](#fig2){ref-type="fig"} and [S2, A and B](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp4}). We first focused on the untreated extracts. In the less extractable fraction, little of the bait was recovered, and only NUFIP and some proteasomal subunits could be identified with high specificity and high SILAC ratios. In the more extractable fraction, however, the six proteins previously identified with hBCD1 as the bait were also found (NUFIP, RuvBL1, RuvBL2, hBCD1, ZNHIT3, and 15.5K), and we additionally detected the C/D core protein Nop58. This indicated that the hBCD1 and ZNHIT3 complexes represent a similar entity, which would thus be composed of five assembly factors bound to two core proteins.

![**ZNHIT3 forms a complex containing Nop58 and 15.5K as well as five assembly factors.** (A) Proteomic analysis of GFP-ZNHIT3. X axis: protein abundance (Log~10~); Y axis: SILAC ratios (specific vs. control IP). LC, liquid chromatography; M/L, medium/light; MW, molecular weight. (B) Proteomic analysis of GFP-ZNHIT3, in the presence and absence of RNase treatment. X axis: SILAC ratios (specific vs. control IP) in the presence of RNase treatment; Y axis: SILAC ratios (specific vs. control IP) in the absence of RNase treatment. H/L, heavy/light. (C) Co-IP assays with GFP-NUFIP, GFP-hBCD1, and GFP-15.5K. 293T cells were transiently transfected with the indicated proteins, extracts were purified on GFP-TRAP beads, and pellets were analyzed by Western blots with the indicated antibodies. When indicated, extracts were treated with 0.6 µg/ml RNase. Pellets: 5% of inputs.](JCB_201404160_Fig2){#fig2}

To investigate the presence of nascent snoRNA in the GFP--ZNHIT3 complex, we compared immunopurifications performed with and without RNase treatment. When the SILAC ratios measuring the enrichment over control were plotted against one another, all seven proteins of the complex were found on the diagonal of the plot, indicating that their association with ZNHIT3 was not affected by the RNase treatment ([Fig. 2 B](#fig2){ref-type="fig"}; similar results were obtained using protein abundance instead of SILAC ratio, Fig. S2 A). This was further confirmed by transfecting GFP-15.5K, GFP-Nop58, and GFP-hBCD1 in 293T cells and by analyzing the coprecipitated proteins by Western blot, either with, or without, RNase treatment. Indeed, all three proteins coprecipitated NUFIP, ZNHIT3, and RuvBL1, and their association was not affected by the presence or absence of RNase ([Fig. 2 C](#fig2){ref-type="fig"}). Thus, these results raised the possibility that the ZNHIT3 complex was a protein-only molecular assembly. In the following, we refer to pre-snoRNPs complexes as a general term whether these complexes contain snoRNAs or not.

ZNHIT3 associates preferentially with assembly-defective U3 snoRNAs
-------------------------------------------------------------------

To investigate more directly the association of ZNHIT3 with C/D snoRNAs, we measured its binding to U3 by RNase protection assays and compared it to other assembly factors. A rat U3 gene was transfected in HeLa cells, either alone, or with tagged versions of ZNHIT3, RuvBL1, or hBCD1. Extracts were immunoprecipitated using appropriate antibodies, and the pelleted RNAs were analyzed with a probe covering the 3′ end of rat U3, such that both precursor and mature forms of the snoRNA could be identified and discriminated from the endogenous human U3 ([@bib5]). We used two forms of U3: a wild-type gene and mutant carrying three point mutations in stem II (U3mut6; [Fig. 3 A](#fig3){ref-type="fig"}), which were previously shown to reduce association with Nop56, Nop58, and Fibrillarin ([@bib64]). In agreement, it prevented most of the accumulation of U3 snoRNA in the nucleolus ([Fig. 3 B](#fig3){ref-type="fig"}), and it led to the accumulation of the precursor forms of U3 at the expense of the mature form ([Fig. 3, C--F](#fig3){ref-type="fig"}, compare U3-I, U3-II, and U3-m in the input lanes). This mutant was thus mostly defective for assembly, although not completely inactive. We found that NUFIP, hBCD1, and RuvBL1 bound similarly to precursors and mature forms of rat U3 ([Fig. 3, C--F](#fig3){ref-type="fig"}). In contrast, we failed to detect an association of ZNHIT3 with either the precursor, or mature forms, of wild-type U3 ([Fig. 3 D](#fig3){ref-type="fig"}). Unexpectedly, however, we could observe binding of ZNHIT3 to the precursor forms of the U3mut6 mutant. Collectively, these data suggest that the protein complex identified with ZNHIT3 is indeed devoid of snoRNAs and that binding of this complex to wild-type U3 induces the loss of ZNHIT3. In the case of U3mut6, assembly of the complete snoRNP is delayed, and ZNHIT3 remains in the complex. This indicates an assembly scheme in which a protein-only complex composed of ZNHIT3, hBCD1, NUFIP, RuvBL1/2, Nop58, and 15.5K binds nascent snoRNAs and then rapidly releases ZNHIT3, whereas NUFIP and RuvBL1/2 remain bound until late stages of maturation. Hence, the protein-only pre-snoRNP complex appears to be remodeled upon its binding to nascent snoRNAs.

![**ZNHIT3 associates preferentially with assembly defective U3 snoRNAs.** (A) Schematic of the U3mut6 mutant. (B) Intracellular localization of U3mut6. HeLa cells were transfected with the U3wt and U3mut6 gene and hybridized in situ with a probe specific for the transfected rat U3 gene. Arrows on the merged image point to a Cajal body that is zoomed in the insets. Bars: (main images) 10 µm; (insets) 0.6 µm. (C--F) Binding of NUFIP (C), ZNHIT3 (D), RuvBL1 (E), and hBCD1 (F) to U3 snoRNAs. HeLa cells were transfected with the indicated plasmids, extracts were immunopurified on glutathione beads, and RNAs in the pellet were analyzed by RNase protection with a probe covering the 3′ end of the transfected rat U3 gene. Ct: control IP with empty beads. Pre-U3-I, pre-U3-II, and pre-U3-III: precursor forms of U3 snoRNA. U3m: mature form of U3. Pellets: 5% of inputs.](JCB_201404160_Fig3){#fig3}

GFP-NUFIP proteomics reveals association with splicing factors
--------------------------------------------------------------

To further characterize the assembly pathway of box C/D snoRNPs, we performed a SILAC experiment using GFP-NUFIP as the bait ([Fig. 4 A](#fig4){ref-type="fig"}). In the highly extractable fraction, we detected large amounts of ZNHIT3 and a weaker association with the snoRNP core proteins 15.5K and Nop58. Given the strong association of ZNHIT3 with both the RuvBL1/2 proteins and NUFIP, the absence of RuvBL1/2 in the NUFIP SILAC was surprising. This could be caused either by a lack of association with NUFIP, by a dissociation of these proteins during cell fractionation, or by a limited sensitivity of our proteomic experiment. To test these possibilities, we immunopurified GFP-NUFIP in various conditions and analyzed for the presence of RuvBL1 and RuvBL2 by Western blotting. Both proteins copurified with GFP-NUFIP, but they could be detected only when the extracts were not fractionated ([Fig. 4 B](#fig4){ref-type="fig"}). This suggested that the association of RuvBL1/2 with NUFIP was more labile than those formed with ZNHIT3 or hBCD1.

![**SILAC proteomic analysis of GFP-NUFIP reveals binding to snoRNAs.** (A) Proteomic analysis of GFP-NUFIP. X axis: protein abundance (Log~10~); Y axis: SILAC ratios (Log~10~ specific vs. control IP). CTL, control; LC, liquid chromatography; H/L, heavy/light; MW, molecular weight. (B) Co-IP assays with GFP-NUFIP. U2OS cells were extracted in HNTG, extracts were purified on GFP-TRAP beads, and pellets were analyzed by Western blots (WB) with the indicated antibodies. Pellets: 5% of inputs.](JCB_201404160_Fig4){#fig4}

Interestingly, several differences were observed between the more and the less extractable fraction of GFP-NUFIP immunopurifications ([Fig. 4 A](#fig4){ref-type="fig"}). First, additional proteins were detected in the less extractable fraction: Fibrillarin, the core snoRNP protein that binds Nop58, and a set of splicing factors, including PRPF8, PRPF19, SNRPD1, and SNRNP200. Because most C/D snoRNPs are produced from introns in humans ([@bib43]), this suggested that in this fraction, GFP-NUFIP is associated with snoRNAs. This was also consistent with the detection of RRP9 (also called U3-55K). This protein binds to the B/C motif of U3 ([@bib41]), a very abundant non-intronic C/D snoRNA. Second, the amount of ZNHIT3 copurifying with GFP-NUFIP decreased by more than twofold in the less extractable fraction, whereas at the same time the amount of Nop58 and 15.5K increased by three- and eightfold, respectively ([Fig. 4](#fig4){ref-type="fig"}). This was in agreement with the aforementioned data, which indicated a loss of ZNHIT3 upon binding of the protein-only complex to snoRNAs. The results obtained with GFP-NUFIP thus suggested a progression in snoRNP assembly, in which the protein-only complex becomes bound to nascent snoRNA, leading to ZNHIT3 dissociation and reinforcement of Fibrillarin association.

The release of RuvBL1/2 is a late step during assembly of C/D snoRNPs
---------------------------------------------------------------------

To complete our analysis of the assembly pathway of box C/D snoRNPs, we performed a SILAC proteomic analysis of GFP-Nop58 ([Fig. 5 A](#fig5){ref-type="fig"}). In the less extractable fraction, which is expected to contain nucleoli-derived complexes, we detected the three other C/D core proteins, 15.5K, Fibrillarin, and Nop56, all with high SILAC ratios and high abundance (similar that of the bait itself). We also detected many proteins known to associate with U3, such as RRP9 (U3-55K), La/SSB, and the SSU processosome, indicating that the complexes purified consisted of mature C/D snoRNPs. Consistently, we also detected many nucleolar proteins. In the more extractable fraction, which contains cytoplasmic and nucleoplasmic material, we also detected a specific enrichment of all snoRNP core proteins, including Nop56. They were, however, present in ∼10--100-fold lower abundance relative to Nop58 when compared with the less extractable fraction. We also detected RRP9 and La/SSB, which indicated the presence of U3 snoRNA. We also found RuvBL1/RuvBL2, in amounts larger than Nop56. A novel protein, c12orf45, was also present in high abundance and with a high SILAC ratio. This protein is conserved throughout evolution down to *Schizosaccharomyces pombe* (NCBI EST gene ID 14217966), and it was also previously copurified with RuvBL1 and RuvBL2 ([@bib27]). By performing systematic pairwise two-hybrid tests, we found that it makes a specific interaction with RuvBL1 (Fig. S2 C), and it thus represents a potential new snoRNP assembly factor. The presence of all four core proteins in this complex, together with snoRNAs and RuvBL1/RuvBL2, indicates that this is a late assembly intermediate.

![**SILAC proteomic analyses of GFP-Nop58 and GFP-PIH1D1.** (A) Proteomic analysis of GFP-Nop58. X axis: protein abundance (Log~10~); Y axis: SILAC ratios (specific vs. control IP). (B) Proteomic analysis of GFP-PIH1D1. X axis: protein abundance (Log~10~); Y axis: SILAC ratios (Log~10~ specific vs. control IP). Legend as in A. CTL, control; LC, liquid chromatography; H/L, heavy/light; M/L, medium/light; Fib, Fibrillarin; MW, molecular weight.](JCB_201404160_Fig5){#fig5}

To confirm that c12orf45 is a snoRNP assembly factor, we performed a time-resolved proteomic experiment using a triple SILAC encoding scheme. We transiently transfected HeLa cells with a GFP-Nop58 construct for 10 h, pulled down the associated proteins, and compared them with the proteins bound to a version of GFP-Nop58 that was stably expressed in cells. A plot of the SILAC ratios at 10 h versus the ones at steady-state shows that RuvBL1/2 and c12orf45 preferentially associate with GFP-Nop58 at 10 h, whereas nucleolar proteins associate more strongly at steady state (Fig. S2 D). This indicates that RuvBL1/2 and c12orf45 associate transiently with nascent Nop58 protein.

Proteomic analysis of PIH1D1 identifies the R2TP--prefoldin-like complex
------------------------------------------------------------------------

The R2TP complex has been previously involved in snoRNP biogenesis ([@bib71], [@bib72]; [@bib6]). In humans, it is composed of the conserved core R2TP complex (RuvBL1/RuvBL2, PIH1D1, and RPAP3), together with a set of prefoldins and few other proteins ([@bib6], [@bib8]; [@bib14]). Our proteomic analyses readily detected the RuvBL1/RuvBL2 proteins in most of the pre-snoRNP complexes identified in this paper (i.e., both the protein-only and the RNA-bound complexes) but failed to detect other components of the R2TP complex, despite their known role in snoRNP biogenesis and interactions with C/D core proteins ([@bib22]; [@bib6]; [@bib72]; [@bib45]). One reason could be that the interaction between the RuvBL proteins and PIH1D1/RPAP3 is too labile to survive our purification conditions. To test this possibility, we performed a SILAC experiment using GFP-PIH1D1 as the bait ([Fig. 5 B](#fig5){ref-type="fig"}). In the more extractable fraction, we found large amounts of RPAP3 and nearly all components of the R2TP--prefoldin-like complex, including the key RuvBL1/RuvBL2 proteins. This indicated that the failure to detect PIH1D1 and RPAP3 in the other purifications was not caused by poor stability of the R2TP complex. The purification of PIH1D1 from the less extractable fraction yielded about tenfold less bait, and it was thus difficult to assess reliably the presence or absence of putative partners. We, however, noted that large amounts of RPAP3 still copurified with PIH1D1, suggesting that these two proteins form a stable heterodimer in cells, as they do in vitro ([@bib71]; [@bib6]; [@bib17]).

Meta-analysis of the SILAC proteomic data
-----------------------------------------

Next, we pooled together our proteomic data and performed a meta-analysis to identify protein subcomplexes. First, a graph was made to recapitulate the main interactions found in the proteomic experiments ([Fig. 6 A](#fig6){ref-type="fig"}). This nicely showed that NUFIP, ZNHIT3, hBCD1, and RuvBL1/RuvBL2 lie at the heart of the snoRNP assembly mechanism, together with the core proteins 15.5K and Nop58. The R2TP protein lies at the periphery of the network, together with spliceosomal proteins, the other C/D core proteins, and U3-specific proteins. Next, we used the SILAC enrichment data to perform a clustering analysis ([Fig. 6 B](#fig6){ref-type="fig"}). Three groups of assembly factors were found. The first corresponds to the NUFIP/ZNHIT3 pair, the second to PIH1D1/RPAP3, and the third to hBCD1/RuvBL1/RuvBL2, with RuvBL1/RuvBL2 placed close to each other. This nicely corresponded to the protein--protein interactions identified from yeast two-hybrid assays or from in vitro reconstitution of protein complexes. Indeed, PIH1D1 interacts with RPAP3 in yeast two-hybrid assays and GST pull-down experiments ([@bib6], [@bib8]), and the yeast proteins form a stable complex in vitro ([@bib71]; [@bib17]), whose structure was recently solved ([@bib2]; [@bib49]). Likewise, RuvBL1/RuvBL2 are well known to heteromultimerize ([@bib23]), and RuvBL2 also directly interacts with hBCD1 in yeast two-hybrid and in vitro assays (this study and [@bib45]). Finally, we show here that NUFIP and ZNHIT3 make an evolutionarily conserved interaction. Collectively, this suggests that these modules correspond to protein subcomplexes that form the building blocks of the snoRNP assembly machinery. It is also interesting to note that Nop58 clusters away from the other core C/D snoRNP proteins. This is in line with the idea that it plays a particular role during snoRNP assembly.

![**Meta-analysis of the proteomic data.** (A) Network analysis of the factors involved in snoRNP biogenesis. The interactions detected by SILAC proteomics were used to create an interaction network using Cytoscape. (B) Clustering analysis of the proteomic data. SILAC ratio was used to perform a clustering analysis. Columns: baits, −1 is the less extractable fraction and −2 is the more extractable fraction. Rows: preys.](JCB_201404160_Fig6){#fig6}

Crystal structure of the Snu13p--Rsa1~239--265~ complex
-------------------------------------------------------

The aforementioned data suggested that several remodeling steps occur during C/D snoRNP biogenesis, and they reinforced the idea of a central role of NUFIP. Indeed, NUFIP binds directly to 15.5K ([@bib6]), the protein that nucleates C/D snoRNP, and it is present through most of the snoRNP assembly pathway, from early protein-only complexes until late assembly intermediates. To better understand the function of NUFIP during snoRNP assembly, we turned to structural approaches. We previously showed that the PEP domain of NUFIP is sufficient to bind to 15.5K and that this interaction is conserved between the yeast proteins (Rsa1p and Snu13p, respectively; [@bib51]). We found that a fragment of yeast PEP (residues 238--290 of Rsa1p) formed a stable complex with full-length Snu13p and gave high quality crystals after purification to homogeneity (see Materials and methods). The structure was solved by single anomalous diffraction and was refined to a final resolution of 1.55 Å ([Table S2](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp5}).

In the crystal structure, the PEP domain of Rsa1p consists of a long α helix of 17 residues at the N terminus, a short loop of three residues and a short α helix of five residues at the C terminus. The N-terminal α helix of Rsa1~239--265~ lies in a groove at the surface of Snu13p that is delineated by the helix α3 and the C-terminal helix α5 ([Fig. 7, A and B](#fig7){ref-type="fig"}). Comparison of Snu13p complexed to Rsa1p with Snu13p in a free state ([@bib48]; Protein Data Bank \[PDB\] accession no. [1ZWZ](1ZWZ)) yields a root-mean-square deviation of Cα positions of 1.28 Å. This is reduced to 0.54 Å without the last 20 residues of Snu13p, indicating a rigid-body movement of ∼3 Å of the C-terminal helix α5 of Snu13p upon binding of Rsa1~239--265~ ([Fig. 7 C](#fig7){ref-type="fig"}).

![**The PEP domain of Rsa1p lies in a groove at the surface of Snu13p.** (A and B) Ribbon representation (A) and molecular surface (B) of the complex between Snu13p and Rsa1~239--265~, obtained from the crystal structure of the complex. A and B are in the same orientation. (C) Superimposition of Snu13p bound to Rsa1p with Snu13p in free state (PDB no. [ZWZ](ZWZ)). Upon interaction with Rsa1~239--265~, a rigid-body movement of ∼3 Å of the α5 helix is observed in Snu13p. (D--G) Electrostatic properties of protein Snu13p (D and E) and Rsa1~239--265~ (F and G). The electrostatic potentials were computed by using the algorithm of Boltzmann available on the Swiss-PdbViewer. Blue, white, and red regions correspond to positive, neutral, and negative electrostatic potentials, respectively. (D and E) Electrostatic potential mapped on the molecular surface of Snu13p and viewed in two different orientations (rotation by 90°). Rsa1~239--265~ is shown in magenta in a ribbon representation. (F and G) Electrostatic potential mapped on the molecular surface of Rsa1~239--265~ and viewed in two opposite directions.](JCB_201404160_Fig7){#fig7}

Complementary electrostatic surface potentials favor Snu13p--Rsa1p interaction
------------------------------------------------------------------------------

The peculiar location of acidic and basic residues of Snu13p results in an asymmetric electrostatic surface potential ([Fig. 7 D](#fig7){ref-type="fig"}), with one negatively charged and one positively charged face (the one that binds the K-turn RNA motif). As found for the archaeal homologous L7Ae protein ([@bib11],[@bib12]), this electrostatic property favors RNA--protein association. The electrostatic potential at the surface of Rsa1~239--265~ is almost fully positive ([Fig. 7, D--G](#fig7){ref-type="fig"}), and it binds the negatively charged face of Snu13p, which should favor the Snu13p--Rsa1p interaction.

Functionally important hydrophobic and polar interactions at the Snu13p--Rsa1p interface
----------------------------------------------------------------------------------------

In the established structure, a single and continuous surface of Snu13p is buried by Rsa1p~239--263~ ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp6}). It involves residues of helix α3, strand β3, loop α3-β3, the N-terminal loop, and the C-terminal helix α5. These proteins form four distinct networks of interactions, which are nicely supported by our previous biochemical work. First, residues K118, D119, and E122 in helix α5 of Snu13p form hydrogen bonds with residues S258, N259, and I257 of Rsa1p ([Fig. 8 A](#fig8){ref-type="fig"}). Accordingly, I257A substitution in Rsa1p strongly reduces the interaction strength ([@bib51]). Second, residues L65 and L69 establish hydrophobic contacts with helix α3 in Snu13p and W245 of Rsa1p ([Fig. 8 B](#fig8){ref-type="fig"}), explaining why Snu13p L69A and Rsa1p W245A substitution have strong deleterious effects on the interaction ([@bib51]). Third, in agreement with the need for Snu13p E72 and Rsa1p R249 to form the complex ([@bib51]), a strong ionic interaction is formed between these residues ([Fig. 8 B](#fig8){ref-type="fig"}). Finally, the hydrophobic residue W253 of Rsa1~239--265~ tightly binds in a hydrophobic pocket of Snu13p ([Fig. 8 C](#fig8){ref-type="fig"}), which is formed by residues P10, P77, Y78, and K118, I121, E122, and L125 ([Fig. 8 D](#fig8){ref-type="fig"}). Interestingly, these last residues are in the helix α5 of Snu13p that moves upon Rsa1p binding, suggesting an important role of this movement.

![**Hydrogen bonds, ionic interaction, and hydrophobic contacts at the Snu13p--Rsa1p interface.** (A) Network of hydrogen bonds between Snu13p and Rsa1p. (B) Hydrophobic contacts and ionic interaction between Snu13p and Rsa1p. (C and D) The residue W253 of Rsa1p tightly binds in a hydrophobic pocket at the molecular surface of Snu13p.](JCB_201404160_Fig8){#fig8}

Interestingly, most of the detected contacts also appear to be conserved in the human proteins ([Fig. S4, A and B](http://www.jcb.org/cgi/content/full/jcb.201404160/DC1){#supp7}; [@bib59]; [@bib51]). In particular, W253 in Rsa1p is substituted into a homologous aromatic residue Y247 in NUFIP (Fig. S4), and the structure of 15.5K also reveals a structurally conserved hydrophobic pocket at its surface, with strictly conserved key residues ([@bib59]). Finally, the in vivo functional importance of several of the identified interactions is supported by the fact that E72A substitution in Snu13p and R245A and R249A substitution in Rsa1p generate a marked growth defect in yeast and that the Rsa1p W245A substitution strongly reduces the efficiency of box C/D snoRNP biogenesis in yeast ([@bib51]). Therefore, although established with an Rsa1p fragment, the present 3D structure is strongly supported by previous biochemical and genetic data obtained with full-length proteins.

Rsa1p/NUFIP is predicted to prevent rotation of the catalytic module of box C/D snoRNPs
---------------------------------------------------------------------------------------

Up to now, no 3D structure of a complete eukaryotic C/D snoRNP is available. However, several crystal structures of their archaeal counterparts have been recently determined ([@bib68]; [@bib67]; [@bib39]). These particles contain of Fibrillarin, L7Ae (the homologue of Snu13p/15.5K), and NOP5 (the homologue of Nop56 and Nop58). The small RNP (sRNP) particle was found in both catalytically active and inactive states, and both types of structures have been solved at high resolution ([@bib68]; [@bib67]; [@bib39]; [@bib34]). The main difference between these two states involves the catalytic module comprising Fibrillarin and the N-terminal domain of NOP5. Indeed, this module is located far away from the RNA modification site in the inactive state, and it needs to make a large rotation to adopt a catalytically active form ([@bib39]). On the basis of this archaeal structure, a similar architecture can be proposed for human snoRNPs ([Fig. 9](#fig9){ref-type="fig"}). Importantly, modeling of the eukaryotic pre-snoRNP complex predicts that the presence of NUFIP should be compatible with the structure of C/D snoRNPs in an open inactive form ([Fig. 9](#fig9){ref-type="fig"}, left). However, according to these structural predictions, the rotation of the catalytic module that is required to adopt a closed active form of the C/D snoRNP would lead to a steric clash between the second α helix of the PEP domain of NUFIP and the N-terminal domain of Nop58 ([Fig. 9](#fig9){ref-type="fig"}, right). Thus, the presence of NUFIP (or Rsa1p in yeast) in the pre-snoRNP complexes is expected to prevent formation of the catalytically active structure and to inhibit their catalytic activity. A formal demonstration that this is the case will, however, require additional studies with eukaryotic C/D snoRNPs: the resolution of their structure or the development of a suitable in vitro methylation assay.

![**Binding of Rsa1p to Snu13p prevents formation of the catalytically active structure of box C/D snoRNP.** Model of the human box C/D snoRNP comprising the core proteins 15.5K, Nop58, and Fibrillarin in inactive (left) and active (right) states. Both states were shown in two orthogonal views (up and down representations). The PEP domain of the protein factor NUFIP is represented in magenta. Whereas the presence of NUFIP~233--258~ is compatible with the structure of the inactive form (comprising Nop58, Fibrillarin, and 15.5K), the rotation of the catalytic module of the box C/D snoRNP (including Fibrillarin and the N-terminal domain of Nop58) leads to a clash between the second α helix of NUFIP~233--258~ and the N-terminal domain of Nop58. The region of spatial hindrance between NUFIP and Nop58 is indicated with a red dashed circle. Model was built on the basis of the known 3D structures of the box C/D sRNP in an inactive state from *P. furiosus* (([@bib67]); PDB no. [3NMU](3NMU)), in an active state from *S. solfataricus* ([@bib39]; PDB no. [3PLA](3PLA)), and the crystal structure of Snu13p--Rsa1~239--265~ (our work). The snoRNA is not depicted on these pictures.](JCB_201404160_Fig9){#fig9}

Discussion
==========

How box C/D snoRNPs are assembled in vivo is not well understood. Here, by using a combination of SILAC proteomics and structural biology approaches, we propose an assembly pathway that has three main features: (1) a protein-only complex that preassembles Nop58 and 15.5K, (2) the robust presence of RuvBL1/2, but not the other components of the R2TP complex, throughout most of the assembly pathway, and (3) the incompatibility between the presence of NUFIP and the formation of a catalytically active snoRNP structure.

ZNHIT3 and HIT Zn-finger proteins display tight links with RuvBL proteins
-------------------------------------------------------------------------

Using hBCD1 and NUFIP as baits, our proteomic experiments have identified ZNHIT3 as a new C/D snoRNP assembly factor. This protein is conserved across evolution, appears to interact directly with NUFIP, and forms a protein-only complex containing Nop58, 15.5K, NUFIP, hBCD1, RuvBL1, and RuvBL2. Such a preassembly of snoRNP proteins differs significantly from scenarios derived from in vitro experiments, from which a sequential recruitment of core proteins was proposed ([@bib64]; [@bib52]). Interestingly, although we did not detect association of ZNHIT3 with wild-type U3 snoRNA, we found that it bound well to a mutant form of U3 that carries three point mutations in stem II of the box C′/D motif. This mutant was previously shown to bind 15.5K but is impaired in its ability to form a complete C/D snoRNP because of missing contacts with Nop58 ([@bib64]; [@bib68]; [@bib67]). This suggests that the protein-only complex can bind RNA through 15.5K and that proper binding of Nop58 to the C/D motif triggers the release of ZNHIT3.

It is interesting to note that HIT Zn-finger proteins appear to have evolved specific links with the AAA^+^ ATPases RuvBL1/2. There are six such proteins in the human genome (ZNHIT1--6). Two of them are involved in snoRNP biogenesis and are tightly associated with RuvBL1/2 in cells (ZNHIT3 and hBcd1/ZNHIT6; this study). Two other HIT Zn-finger proteins, ZNHIT1 and ZNHIT4, are part of the chromatin remodeling complexes SRCAP and Ino80, respectively, and RuvBL1/2 are also key components of these complexes. In addition, recent structural data of the yeast Ino80 complex indicates that the orthologue of ZNHIT4, Ies2p, makes many direct contacts with RuvBL1/2 and plays a central role in connecting them to the rest of the complex ([@bib56]). The remaining HIT Zn-finger proteins, ZNHIT2 and ZNHIT5/DDX59, are poorly characterized, but ZNHIT2 has also been found to be tightly associated with RuvBL proteins ([@bib27]). Collectively, these data thus suggest that ZNHIT proteins may contribute to the substrate specificity of RuvBL1/2. In addition, because hBCD1/ZNHIT6 makes ATP-dependent contact with RuvBL1/2 ([@bib45]), and because ZNHIT3 appears to be released upon binding of the pre-snoRNP complex to snoRNAs, it is tempting to speculate that HIT Zn-finger proteins may play a particularly important role in the regulation of the activity and function of the RuvBL 1/2 proteins.

An assembly pathway for box C/D snoRNP points to the role of NUFIP in controlling snoRNP catalytic activity
-----------------------------------------------------------------------------------------------------------

Our structural data suggest that binding of NUFIP to the 15.5K protein prevents formation of the catalytically active snoRNP structure, and our proteomic and RNA binding experiments indicate that NUFIP remains bound to pre-snoRNPs until late stages of maturation. This indicates that one function of NUFIP is likely to prevent premature activation of the snoRNP catalytic activity. This is also reminiscent of H/ACA snoRNPs. In this case, the pre-snoRNPs contain Naf1 instead of Gar1. Naf1 is a structural homologue of Gar1 but it lacks a C-terminal domain that is required for substrate turnover ([@bib37]). Similar cases also occur during ribosome maturation ([@bib29]), and inhibition of the activity of immature noncoding RNP particles thus appears to be a general strategy during RNP biogenesis.

Collectively, our proteomic experiments and binding studies on U3 snoRNA allows us to propose an assembly scheme for box C/D snoRNPs ([Fig. 10](#fig10){ref-type="fig"}). It has three intermediates. First, a protein-only complex that contains ZNHIT3, NUFIP, hBCD1, and RuvBL1/2 associated with 15.5K and Nop58. Second, a box C/D snoRNA is incorporated to the nascent particle, and Fibrillarin interacts with Nop58. During this stage, the protein factor ZNHIT3 is released, whereas NUFIP is still bound to 15.5K to prevent the snoRNP from becoming catalytically active. Finally, Nop56 interacts with Nop58, whereas hBCD1 and NUFIP are released. The large rotation of the catalytic module (Fibrillarin and the N-terminal domain of Nop58) allowed by the release of NUFIP then leads to an active closed form of the box C/D snoRNP. In this closed configuration, the Nop58/Fibrillarin dimer interacts with the tip domain of Nop56 as well as with the snoRNA to direct 2′-*O*-methylation of the RNA target. Thus, Nop56 would play a major role in locking and stabilizing the box C/D snoRNP in a closed active configuration.

![**An assembly scheme for human box C/D snoRNPs.** Complexes identified in the SILAC experiments were ordered according to the presence or absence of RNA and the presence of increasing numbers of core snoRNP proteins. The putative role of the R2TP complex is represented. Fib, Fibrillarin.](JCB_201404160_Fig10){#fig10}

The R2TP complex: A role in loading/unloading RuvBL 1/2 proteins?
-----------------------------------------------------------------

RuvBL1/2 are AAA^+^ ATPases that play an essential role during snoRNP formation ([@bib30]). In agreement, our proteomic and IP analyses indicate that they are present throughout the entire assembly pathway of box C/D snoRNPs. The R2TP complex is also involved in snoRNP biogenesis and contains the PIH1D1--RPAP3 heterodimer in addition to RuvBL1/2 (Pih1p and Tah1p in yeast; [@bib71]; [@bib6]; [@bib17]). However, our proteomic analysis failed to identify either PIH1D1, or RPAP3, in any of the pre-snoRNP complexes found. Interestingly, RuvBL1/2 have been shown to make mutually exclusive ATP-dependent contacts with hBCD1 and PIH1D1: they bind hBCD1 when loaded with ATP and PIH1D1 in the absence of nucleotides ([@bib45]; [@bib13]). This mutually exclusive binding nicely correlates with our proteomic data: hBCD1, but not PIH1D1--RPAP3, is present in most of the pre-snoRNP complexes, whereas PIH1D1--RPAP3, but not hBCD1, is present in the R2TP--prefoldin-like complex. This would suggest that RuvBL1/2 are not bound to ATP when present within R2TP and are ATP loaded in pre-snoRNP complexes and thus unable to bind the PIH1D1--RPAP3 heterodimer.

One interesting hypothesis for the role of the R2TP would thus be that it loads/unloads RuvBL1/2 proteins on target complexes in an ATP-dependent manner ([Fig. 10](#fig10){ref-type="fig"}). Interestingly, PIH1D1 interacts with both Nop58 and NUFIP ([@bib22]; [@bib6]; [@bib72]), and NUFIP can itself form a separate ternary complex with 15.5K and ZNHIT3 ([@bib6]; this work and our unpublished data). The PIH1D1--RPAP3 dimer bound to RuvBL1/2 might thus connect Nop58 to the ZNHIT3--NUFIP--15.5K ternary complex and may stimulate the ATP-dependent transfer of the RuvBL proteins from the R2TP to pre-snoRNPs, which would generate the protein-only, ZNHIT3 complex. In agreement with such a role of the R2TP complex, we found that yeast Nop58p mutants unable to interact with Snu13p/15.5K and to assemble into a snoRNP interact more strongly with both Pih1p and Tah1p by two-hybrid assays (Fig. S4 C).

A role for the R2TP in loading and unloading the RuvBL proteins would explain why several complexes that contain these proteins lack PIH1D1 and RPAP3. This would suggest that many of these complexes, and in particular Ino80 and Swr1, are in fact clients of the HSP90--R2TP chaperone complex, with some of their subunits passing from HSP90 to RuvBL 1/2 via R2TP.

Materials and methods
=====================

Plasmids, cell lines, and antibodies
------------------------------------

HeLa, U2OS, and 293T cells were cultivated in DMEM with antibiotics and 10% FCS. Stable U2OS cells lines were obtained by cotransfecting the GFP-expressing plasmid with a pCMV-Hygro selection plasmid. Clones were selected on 50 mM hygromycin B (EMD Millipore), picked, expended individually, and characterized by Western blots and by GFP fluorescence microscopy. Stable isogenic 293T cells expressing the GST-tagged proteins were obtained with 293T Flp-In cells, by cotransfecting the parental cells with pcDNA5-GST-NUFIP and pcDNA5-GST-ZNHIT3 and a Flippase expression vector with Lipofectamine and Plus reagent (Invitrogen). Stable clones were then selected with hygromycin B and processed as U2OS clones. Individual clones usually expressed similar levels of the tagged protein. DNA cloning was performed by standard techniques and with the Gateway system (Invitrogen). Antibodies and dilutions for Western blots were the following: rabbit polyclonal anti--human NUFIP (Proteintech Group) at 1:1,000, rabbit polyclonal anti---human ZNHIT3 (Abcam) at 1:5,000, rabbit polyclonal anti--human RuvBL1 (Proteintech Group) at 1:1,000, rabbit polyclonal anti--human RuvBL2 (Proteintech Group) at 1:1,000, rabbit polyclonal anti-Nop58 raised against the N-terminal region of human Nop58 (residues 20--37; Eurogentec) at 1:2,000, and rabbit polyclonal anti-GFP (Molecular Probes) at 1:8,000.

IP and RNA analyses
-------------------

Cells were extracted in HNTG buffer (20 mM Hepes, pH 7.9, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM MgCl~2~, 1 mM EGTA, and protease inhibitors) for 30 min at 4°C. Cellular debris were removed by centrifugation (10 min at 9,000 *g*). Extracts were put on antibody-coated beads for 2 h at 4°C (GFP-TRAP for GFP, obtained from ChromoTek; glutathione beads for GST, obtained from GE Healthcare). Beads were washed twice in HNTG and three times in PBS, and pelleted materials were homogenized in TRIZOL (Invitrogen). RNAs were purified according to the manufacturer's instructions. RNase protection assays were performed with RNAPIII kit (Ambion), with ^32^P-labeled probes spanning the 3′ end of rat U3 snoRNA covering nucleotides 98--236 of rU3B.7 (1 is first nucleotide of mature U3; [@bib58]).

Fluorescence microscopy, image acquisition, and quantification
--------------------------------------------------------------

Cells were grown on coverslips, washed in PBS, and fixed in 4% (wt/vol) formaldehyde in PBS at RT (for 20 min) followed by permeabilization either with 0.1% Triton X-100 in PBS for 5 min at RT for antibody labeling or with ethanol 70%, overnight at 4°C for in situ hybridizations, which were performed with Cy3-labeled oligonucleotides against rat U3 as previously described ([@bib58]). Coverslips were mounted on glass slides using mounting medium (Vectashield), and samples were observed at RT using a fluorescence microscope (100×, NA 1.4; DMRA; Leica). Images were acquired with a camera (CoolSNAP HQ2; Princeton Instrument) using MetaMorph (Molecular Devices) and processed with Photoshop (Adobe).

In vitro GST pull-downs
-----------------------

GST-Hit1p was expressed in *Escherichia coli* BL21(DE3) and purified on glutathione beads. Radiolabeled Rsa1p protein was synthesized in the presence of \[^35^S\]methionine in rabbit reticulocyte lysate (TNT; Promega). Binding was performed with 5 µg GST-Hit1p in 20 mM Tris-HCl, pH 8, 40 mM KCl, 1 mM MgCl~2~, 0.1 mM EDTA, 0.1% NP-40, and 10% glycerol. Washing was performed with the same buffer but with 100 mM KCl instead of 40 mM and 5 mM MgCl~2~ instead of 1 mM. Gels were transferred to membranes and subjected to autoradiography.

Yeast two-hybrid assays
-----------------------

Appropriate pACT2 and pAS2ΔΔ plasmids were introduced into haploid *Saccharomyces cerevisiae* test strains (CG1945 and Y187, respectively), which were then crossed. Diploids were selected on −Leu −Trp media and then plated on test plates lacking Leu, Trp, and His. This was used to evaluate the strength of the interactions. Growth was assessed after 3 d of incubation at 30°C. The score is then given by comparing the number of diploid clones growing on −L −T (selections of diploids) and −L −T −H plates (selection for interaction).

SILAC proteomic analysis
------------------------

SILAC experiments were performed as previously described ([@bib8]). Cells were grown in custom-made DMEM (minus arginine and lysine; Invitrogen) supplemented with 10% dialyzed FCS (Biowest) and penicillin-streptomycin (Invitrogen). [l]{.smallcaps}-arginine and [l]{.smallcaps}-lysine (Sigma-Aldrich) were added to the "light," [l]{.smallcaps}-arginine ^13^C and [l]{.smallcaps}-lysine 4,4,5,5-D4 (Eurositop) were added to the "medium," and [l]{.smallcaps}-arginine ^13^C/^15^N and [l]{.smallcaps}-lysine ^13^C/^15^N (Eurositop) were added to the "heavy" media. The amino acid concentrations were based on the formula for normal DMEM (Invitrogen). U2OS cells were grown for 10 d in each isotopically labeled media to ensure complete incorporation of isotopic amino acids and treated with the indicated drugs at 75% confluence for the last 14 h. Five 15-cm diameter plates were used per SILAC condition. Cells were rinsed with PBS at 4°C, trypsinized, and extracted a first time for 10 min at 4°C in 20 mM Tris HCl, pH 7.5, 10 mM KCl, 3 mM MgCl~2~, 0.1% NP-40, 10% glycerol, and Complete antiprotease cocktail (Roche). After centrifugation at 750 *g* for 10 min, pellets were extracted a second time 4°C in 50 mM Tris HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, and Complete antiprotease cocktail and sonicated for 3 × 10 s. Extracts were cleared by centrifugation at 2,800 *g* for 10 min at 4°C to remove cellular debris. An aliquot of each extract was kept and subjected to Western blotting to verify the action of the drugs. The first extraction corresponded to the more extractable fraction, and the second extraction was the less extractable fraction. When indicated, extracts were treated with 0.6 µg/ml RNase A. For all IP experiments, extracts were precleared by incubation on protein G Sepharose beads (GE Healthcare) for 1 h at 4°C. Extracts labeled with light, medium, and heavy amino acids were pooled in a 1:1:1 ratio based on total protein concentration and incubated with GFP-TRAP beads for 2 h at 4°C. The control, light extracts originated from parental cells that did not express the GFP fusion. After the affinity purification step, beads were washed five times with the extraction buffer. Bound proteins were eluted by adding 1% SDS to the beads and boiling for 10 min. Samples were then reduced with 10 mM DTT (BDH Chemicals) at 95°C for 2 min and alkylated using 50 mM iodoacetamide (Sigma-Aldrich) for 30 min. Proteins were separated on 1D SDS/PAGE, the lanes of interest were cut in 10 slices, and proteins were in-gel digested by trypsin in 20 mM NH~4~HCO~3~ (Trypsin Gold; Promega). Peptides were extracted from gel pieces, dried, and resuspended in 0.1% formic acid solution for analysis on a mass spectrometer (Orbitrap Elite Hybrid Ion Trap; Thermo Fisher Scientific) coupled to a nanoflow liquid chromatography system (UltiMate U3000; Thermo Fisher Scientific). One tenth of each band digest was loaded onto a PepMap C18 trap column (0.3-mm inner diameter × 5 mm; Dionex Corporation) with a constant flow of 20 µl/min. After trap enrichment peptides, a gradient consisting of 2--40% buffer B (3--33 min), 40--80% B (33--34 min), 80--0% B (49--50 min), and equilibrated for 20 min in 0% B (50--70 min) was used to elute peptides at 300 nl/min from a PepMap capillary (0.075 mm × 150 mm) reversed-phase column (LC Packings). Mass spectra were acquired using a top-20 collision-induced dissociation data-dependent acquisition method. The LTQ-Orbitrap was programmed to perform a Fourier transform (FT) full scan (60,000 resolution) on 400--1,400-Th mass range with the top 20 ions from each scan selected for LTQ-MS/MS. FT spectra were internally calibrated using a single lock mass (445.1200 Th). Target ion numbers were 500,000 for FT full scan on the Orbitrap and 10,000 MS2 on the LTQ. Quantitation was performed using the program MaxQuant (version 1.4.1.2; [@bib15]) and with the Mascot search engine (version 2.1.04; Matrix Science). Enzyme specificity was set to that of trypsin, allowing for cleavage N-terminal to proline residues and between aspartic acid and proline residues. Other parameters used were (a) variable modifications: methionine oxidation and protein *N*-acetylation; (b) fixed modifications: cysteine carbamidomethylation; (c) database: target decoy human MaxQuant; (d) heavy labels: R6K4 and R10K8; (e) MS/MS tolerance: 0.5 D; (f) maximum peptide length: 6; (g) top MS/MS peaks per 100 D: 6; (h) maximum missed cleavages: 2; (i) maximum of labeled amino acids: 3; and (j) false discovery rate: 5%. In addition to the false discovery rate, proteins were considered to be identified if they had at least one unique peptide, and they were considered quantified if they had at least one quantified SILAC pair, although the number of unique peptides and the number of ratio counts were taken into account during the analysis process to assess the reliability of protein identification and quantification. Proteins labeled as REV (nonreal proteins from the reverse database) were automatically discarded, as well as proteins that did not show any SILAC medium/light, heavy/light, and heavy/medium ratio. SILAC ratios were normalized so that the median enrichment of the specific IP over the control, mostly caused by contaminant proteins, was one. Keratins were removed, and proteins were considered as hits if they had a SILAC ratio (specific IP/control IP) \>3.5 or if their SILAC ratio was between 1.5 and 3.5 but with a frequency of detection in unrelated IPs of \<25% ([@bib7]). The network graph was created with Cytoscape, using the hit list of Table S3, filtered to retain only proteins with a role in snoRNP biogenesis. In a second analysis, we used a clustering algorithm to group proteins from all the SILAC performed. To do so, the hit list was filtered to remove all the proteins found only once. Clustering was performed using the EPCLUST server (<http://www.bioinf.ebc.ee/EP/EP/EPCLUST>), using complete linkage (maximum distance) clustering based on linear correlation--based distance (Pearson, centered). Similar protein groups were obtained using *k*-means (eight clusters, correlation-based distance). For the time-resolved SILAC proteomic experiment, GFP-Nop58 was transiently expressed in HeLa cells for 10 h or stably expressed. These cells and control, untransfected cells were isotopically labeled and extracted by cryogrinding, GFP-Nop58 was pulled down using GFP-TRAP beads, and associated proteins were identified by MS. SILAC ratios of the specific versus control IP were normalized by first subtracting the mean ratios of all proteins identified and then by dividing by the ratio found for GFP-Nop58.

Protein overexpression, purification, and crystallization
---------------------------------------------------------

We did not succeed to get crystals suitable for x-ray analysis with the human proteins or when complexes were formed with the previously identified yeast PEP region (residues 230--266 of Rsa1p). However, after several trials, we found that a slightly larger fragment of yeast PEP (residues 238--290 of Rsa1p) formed a stable complex with full-length Snu13p and gave high quality crystals after purification to homogeneity. For preparation of recombinant protein, the coding sequence of yeast Snu13p ORF and the yeast Rsa1~238--290~ fragment from *S. cerevisiae* were PCR amplified and cloned into the expression vectors pnEA-3CH and pnCS, respectively ([@bib16]). *E. coli* BL21(DE3)pRARE2 cells cotransformed with both plasmids were grown at 37°C to an A~600~ of 0.7 in 1 liter of 2YT medium containing 100 µg/ml ampicillin and 30 µg/ml spectinomycin. Protein expression was induced by addition of 0.2 mM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside, and growth was continued overnight at 20°C. For purification of the His6--Snu13p--Rsa1~238--290~ complex, cells were sonicated in buffer A (25 mM Hepes, pH 7.5, 400 mM NaCl, 5 mM 2-mercaptoethanol, and 10 mM imidazole). After 30 min centrifugation at 4°C and 12,000 *g*, nucleic acids from the supernatant were precipitated by addition of 0.0125% polyethylenimine. A second centrifugation was performed for 20 min at 12,000 *g*, and the supernatant was directly incubated with TALON Superflow Metal Affinity Resin (Takara Bio Inc.). The beads were then successively washed with buffer A and buffer B (25 mM Hepes, pH 7.5, 300 mM NaCl, and 5 mM 2-mercaptoethanol). Elimination of the His tag by proteolytic cleavage was directly performed on the beads in buffer B overnight at 4°C, using the PreScission protease (GE Healthcare). The protein complex was further purified to homogeneity by Superdex 75 gel filtration chromatography using buffer C (10 mM Hepes, pH 7.5, and 150 mM NaCl) and concentrated by the use of a 15-ml system (10-kD cutoff; Amicon Ultra; EMD Millipore) to 56 mg/ml final concentration. A His6--Snu13p--Rsa1~238--290~ Se-Met protein complex was overexpressed in *E. coli* B834(DE3) (Met auxotroph) and purified as described for purification of the His6--Snu13p--Rsa1~238--290~ complex.

Crystals of the Snu13p--Rsa1~238--290~ complex were obtained by vapor phase diffusion and grew in mother liquor containing 2.3 M ammonium sulfate and 70 mM sodium citrate buffer, pH 5.0. Drops were made at 20°C by mixing 1 µl of the concentrated proteins mixture (56 mg/ml) and 1 µl of the reservoir solution. The crystals were in space group *P*4~3~2~1~2 with unit cell parameters a = 59.7 Å, b = 59.7 Å, and c = 92.5 Å, and assuming one protein complex in the asymmetric unit, the packing density *V*~M~ is 1.99 Å^3^/D, and the solvent content is 38.3%. Crystals of Se-Met--incorporated proteins were obtained under conditions similar to those used for the wild-type complex.

Diffraction data collection and crystal structure determination
---------------------------------------------------------------

Crystals were flash frozen in liquid nitrogen in the mother liquor with addition of 20% glycerol as a cryoprotectant. A native dataset at 1.55-Å resolution was collected at 100 K on beamline ID14-4 at the European Synchrotron Radiation Facility, with incident radiation at a wavelength of 0.980 Å and a crystal-to-detector distance of 243 mm. Diffraction spots were recorded on a charge-coupled device detector (Q315r; ADSC) with a 1° oscillation and a 0.2-s exposure per charge-coupled device image over a range of 360°. Data were indexed and scaled using XDS ([@bib28]). Indexed intensities were converted to structure factors using TRUNCATE in the CCP4 suite ([@bib66]) without any σ cutoff.

The single anomalous diffraction data from Se-Met Snu13p--Rsa1~238--290~ crystals were collected at absorption peak up to 1.9-Å resolution at the ID14-4 beamline at European Synchrotron Radiation Facility. The dataset was indexed and scaled using XDS ([@bib28]). Three over six possible selenium sites were found and refined at 2.5-Å resolution using SOLVE ([@bib55]), which produced a mean figure of merit of 0.48 and an overall score of 18. After density modification with RESOLVE ([@bib54]), the mean figure of merit was 0.77. Building of the model was performed using Coot ([@bib18]), and the refinement of the crystal structure was performed in the range 40--1.55 Å using REFMAC5 ([@bib57]) with TLS (translation/libration/screw) parameters (two TLS groups). A total of 5% of the native data were selected for *R*~free~ calculations. The model was refined to the final *R*~factor~ of 19.6% and *R*~free~ of 23.2% (Table S2). The asymmetric unit contains one Snu13p--Rsa1~238--290~ complex, 95 water molecules, and one sulfate ion. Because of the lack of density, residues 1--3 and 126 of Snu13p and residues 238 and 266--290 of Rsa1p were not built. They were probably too flexible in the complex to generate a clear electron density. Coordinates of the Snu13p--Rsa1~238--265~ structure have been submitted to the PDB. Over 94% of the residues were within the most favored regions, and no residue was within the disallowed regions in a Ramachandran plot, as defined by PROCHECK ([@bib35]). Averaged B factors were of 26.2 Å^2^ for the protein atoms, 31.5 Å^2^ for water molecules, 22.9 Å^2^ for the sulfate ion, and 26.5 Å^2^ for the whole structure.

Homology modeling of human snoRNP C/D
-------------------------------------

To build the models of the human snoRNP C/D in active and inactive states, we used the crystal structures of the box C/D sRNP in an inactive state from *Pyrococcus furiosus* ([@bib67]; PDB [3NMU](3NMU)) and in an active state from *Sulfolobus solfataricus* ([@bib39]; PDB [3PLA](3PLA)) as well as the crystal structure of Snu13p--Rsa1~239--265~ (our work). Models of the human box C/D snoRNP comprise the protein factor NUFIP~233--258~ and the core proteins 15.5K (PDB 1E7K), Nop58, and Fibrillarin that were obtained using the program Modeller ([@bib19]) with the crystal structures of homologous proteins. The assembly of the human snoRNPs was achieved by applying several steps of least-squares superimpositions of backbone atoms in accordance with the crystal structures of archaeal complexes.

Online supplemental material
----------------------------

Fig. S1 shows interactions between snoRNP assembly factor and C/D core proteins that were tested by IP and Western blot, two-hybrid assays, and in vitro GST pull-down. Fig. S2 shows a plot for two SILAC-IP of ZNHIT3 (with and without RNase) to reveal the RNase-independent interactions of ZNHIT3 and also shows yeast two-hybrid assays with c12orf45 and time-resolved SILAC-IP of GFP-Nop58. Fig. S3 shows that single and continuous surface of Snu13p is buried upon interaction with the PEP domain of Rsa1p. Fig. S4 shows a comparison of yeast Snu13p--Rsa1p with human 15.5K-NUFIP to reveal conservation of residues involved in the interface and also shows a table of two-hybrid assays performed with yeast Nop58p mutants revealing a stronger interaction with Pih1p and Tah1p for Nop58p mutant K311A A314R, which specifically loose interaction with Snu13p. Table S1 shows nomenclature used in this study. Table S2 shows crystallographic statistics. Table S3 shows a hit list of the proteomic experiments and is avialable online as an Excel file. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201404160/DC1>. Additional data are available in the JCB DataViewer at <http://dx.doi.org/10.1083/jcb.201404160.dv>.
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